Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121127) titled 'Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Zhiming Yan

Condition: Age - Related Macular Degeneration (AMD)

Intervention: Drug: Vitamin Supplements

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: July 7, 2026

Target Sample Size: 38

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121127

Published by HT Digital Content Services with permiss...